A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Associated Retina Consultants - Peoria - DocTrials - PPDS, Peoria, Arizona

Retina Research Institute of Texas, Abilene, Texas

Austin Clinical Research, LLC, Austin, Texas